Byooviz Európska únia - nórčina - EMA (European Medicines Agency)

byooviz

samsung bioepis nl b.v. - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; myopia, degenerative - Øyemidler - byooviz is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).

Ximluci Európska únia - nórčina - EMA (European Medicines Agency)

ximluci

stada arzneimittel ag - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - Øyemidler - ximluci is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).

Ranivisio Európska únia - nórčina - EMA (European Medicines Agency)

ranivisio

midas pharma gmbh - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - Øyemidler - ranivisio is indicated in adults for:• the treatment of neovascular (wet) age-related macular degeneration (amd)• the treatment of visual impairment due to diabetic macular oedema (dme)• the treatment of proliferative diabetic retinopathy (pdr)• the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)• the treatment of visual impairment due to choroidal neovascularisation (cnv).

Eylea Európska únia - nórčina - EMA (European Medicines Agency)

eylea

bayer ag - aflibercept - wet macular degeneration; macular edema; diabetes complications - Øyemidler - eylea er indikert for voksne for behandling av:neovascular (våt) aldersrelatert makuladegenerasjon (amd);synshemming på grunn av flekker ødemer sekundært til retinal vene okklusjon (gren rvo eller sentrale rvo);synshemming på grunn diabetiker macular ødemer (dme);synshemming på grunn av begrenset choroidal neovascularisation (nærsynt cnv).

Invega Európska únia - nórčina - EMA (European Medicines Agency)

invega

janssen-cilag international nv - paliperidon - schizophrenia; psychotic disorders - psykoleptiske - invega er angitt for behandling av schizofreni hos voksne og unge 15 år og eldre. invega er angitt for behandling av schizoaffektiv lidelse hos voksne.

Gadovist 1 mmol/ ml Nórsko - nórčina - Statens legemiddelverk

gadovist 1 mmol/ ml

bayer ab - solna - gadobutrol - injeksjonsvæske, oppløsning - 1 mmol/ ml

Hypoloc Comp 5 mg / 12.5 mg Nórsko - nórčina - Statens legemiddelverk

hypoloc comp 5 mg / 12.5 mg

menarini international o.l. sa - nebivololhydroklorid / hydroklortiazid - tablett, filmdrasjert - 5 mg / 12.5 mg

Lodoz 2.5 mg / 6.25 mg Nórsko - nórčina - Statens legemiddelverk

lodoz 2.5 mg / 6.25 mg

merck ab (1) - bisoprololfumarat / hydroklortiazid - tablett, filmdrasjert - 2.5 mg / 6.25 mg

Lodoz 5 mg / 6.25 mg Nórsko - nórčina - Statens legemiddelverk

lodoz 5 mg / 6.25 mg

merck ab (1) - bisoprololfumarat / hydroklortiazid - tablett, filmdrasjert - 5 mg / 6.25 mg

Vetoryl 30 mg Nórsko - nórčina - Statens legemiddelverk

vetoryl 30 mg

dechra regulatory b.v. - trilostan - kapsel, hard - 30 mg